A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
UCLA researchers found that routine PSMA PET/CT scans could help doctors select treatment approaches for the best long-term outcomes in patients with recurring prostate cancer after surgical removal ...
SurvivorNet on MSN
Beloved Coach Fighting Cancer, New England Players Vow To Win For Terrell Williams, 51, As He Fights Prostate Cancer
The Patriots enter the Super Bowl fueled not just by momentum but by deep love for defensive coordinator Terrell Williams, 51, who was diagnosed with prostate cancer early in the season and is ...
To estimate risk of prostate-specific antigen (PSA) relapse after radical radiotherapy (RT) for prostate cancer (PCa), and risk of PCa death after relapse according to Gleason score and time to ...
Caitlin Clark played just 13 games in 2025 due to a groin injury. The Indiana Fever star also suffered a bone bruise while recovering from the health issue, which only affected her recovery before the ...
Around 210,000 budget portable power banks sold exclusively by Amazon USA are being recalled after they were found to have caused 11 fires resulting in both injuries and property damage … The affected ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Prostate-specific antigen (PSA) is a widely used biomarker for prostate cancer (PCa), but its limitations are evident in patients with PSA at boundary level. We present a 61-year-old male with gross ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results